UK pharmaceutical giant AstraZeneca has unveiled a five-year $15 billion investment plan in China through 2030 to expand medicines manufacturing and research and development (R&D), as UK prime minister Keir Starmer visited China at the end of January.
¬ Haymarket Media Limited. All rights reserved.
